Publications by authors named "P Messner-Pellenc"
Article Synopsis
- Recent studies suggest that giving patients a P2Y12 inhibitor (a type of medicine that helps prevent blood clots) right before a heart procedure might not be necessary, so researchers wanted to see what happens if they give it after the procedure starts.
- They looked at patients getting ready for this heart procedure called PCI, with a focus on any health problems that could happen afterward, like heart attacks or bleeding.
- The results showed that giving the medicine after starting the procedure led to few issues for patients, making it a safe option in real life.
Objective: The aim of this study was to comprehensively investigate left atrial (LA) reservoir, conduit, and booster pump functions, as well as their predictors in patients with primary systemic arterial hypertension (HTN) and left ventricular (LV) hypertrophy.
Methods: Thirty patients with HTN and LV hypertrophy, but no history of atrial arrhythmia or heart failure, were compared with 29 normotensive controls. Speckle-tracking echocardiography of the LA wall was used to measure systolic and diastolic strains and strain rates.
Background: Little information is available on the long-term incidence of bleeding events after ST-segment elevation myocardial infarction (STEMI) with the current antithrombotic strategy.
Aims: To evaluate the effect of bleedings for up to 12months on clinical events and therapeutic compliance in unselected STEMI patients treated with prasugrel or clopidogrel.
Methods: Patients were treated with clopidogrel or prasugrel according to guidelines.
[What is the place of bioresorbable vascular scaffolds in setting of ST-segment elevation myocardial infarction?].
Ann Cardiol Angeiol (Paris)
December 2015
A 50-year-old woman was admitted for an inferior ST-segment elevation myocardial infarction; immediate coronary angiogram revealed a subocclusive stenosis of the right coronary artery. After optimal antithrombotic treatment, the type of stent could be discussed. The latest generation of drug-eluting stents showed excellent efficacy and safety in the long-term but has limitations such as potential chronic inflammation of the arterial wall and no recovery of vasoactive function.
View Article and Find Full Text PDFBackground: Abnormal left ventricular (LV) deformational mechanics have been demonstrated in patients with hypertrophic cardiomyopathy (HCM) at rest, but there is a lack of information on their adaptation to exercise. The aim of this study was to assess the adaptability of LV strains and torsional mechanics during exercise in HCM patients.
Methods And Results: Twenty nonobstructive HCM patients (age, 48.